Laszlo Virag
Laszlo Virag
Professor of Medical Chemistry, University of Debrecen, Faculty of Medicine, Hungary
E-mail megerősítve itt: med.unideb.hu - Kezdőlap
CímIdézteÉv
The therapeutic potential of poly (ADP-ribose) polymerase inhibitors
L Virág, C Szabó
Pharmacological reviews 54 (3), 375-429, 2002
15422002
Diabetic endothelial dysfunction: the role of poly (ADP-ribose) polymerase activation
SC Soriano FG, Virag L, Jagtap P, Szabo E, Mabley JG
Nat Med 7, 108-13, 2001
6842001
Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention
L Virág, E Szabo, P Gergely, C Szabo
Toxicology letters 140, 113-124, 2003
5052003
Flagellin, a novel mediator of Salmonella-induced epithelial activation and systemic inflammation: IκBα degradation, induction of nitric oxide synthase, induction of …
T Eaves-Pyles, K Murthy, L Liaudet, L Virág, G Ross, FG Soriano, ...
The Journal of Immunology 166 (2), 1248-1260, 2001
3382001
Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly (ADP-ribose) synthase
C Szabó, L Virág, S Cuzzocrea, GS Scott, P Hake, MP O’Connor, ...
Proceedings of the National Academy of Sciences 95 (7), 3867-3872, 1998
3191998
Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving …
MN Ajuebor, AM Das, L Virág, RJ Flower, C Szabó, M Perretti
The Journal of Immunology 162 (3), 1685-1691, 1999
3101999
Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFκB activation
E Gilad, HR Wong, B Zingarelli, L Virág, M O'Connor, AL Salzman, ...
The FASEB Journal 12 (9), 685-693, 1998
3051998
Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction
P Pacher, L Liaudet, P Bai, JG Mabley, PM Kaminski, L Virág, A Deb, ...
Circulation 107 (6), 896-904, 2003
2982003
Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock
G Haskó, DG Kuhel, ZH Németh, JG Mabley, RF Stachlewitz, L Virág, ...
The Journal of Immunology 164 (2), 1013-1019, 2000
2782000
Poly (ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death
L Virág, AL Salzman, C Szabó
The Journal of Immunology 161 (7), 3753-3759, 1998
2561998
Protection against hemorrhagic shock in mice genetically deficient in poly (ADP-ribose) polymerase
L Liaudet, FG Soriano, É Szabó, L Virág, JG Mabley, AL Salzman, ...
Proceedings of the National academy of Sciences 97 (18), 10203-10208, 2000
2392000
Novel phenanthridinone inhibitors of poly (adenosine 5′-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents
P Jagtap, FG Soriano, L Virág, L Liaudet, J Mabley, É Szabó, G Haskó, ...
Critical care medicine 30 (5), 1071-1082, 2002
2212002
Peroxynitrite‐induced thymocyte apoptosis: the role of caspases and poly (ADP‐ribose) synthetase (PARS) activation
L Virag, GS Scott, S Cuzzocrea, D Marmer, AL Salzman, C Szabo
Immunology 94 (3), 345-355, 1998
2201998
Activation of poly (ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation
L Liaudet, PÁL Pacher, JG Mabley, L Virág, FG Soriano, G HASKÓ, ...
American journal of respiratory and critical care medicine 165 (3), 372-377, 2002
2052002
Part I: pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition …
C Szabó, JG Mabley, SM Moeller, R Shimanovich, P Pacher, L Virág, ...
Molecular Medicine 8 (10), 571-580, 2002
1982002
Activation of poly (ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure
P Pacher, L Liaudet, P Bai, L Virag, JG Mabley, G Hasko, C Szabo
Journal of Pharmacology and Experimental Therapeutics 300 (3), 862-867, 2002
1922002
Suppression of macrophage inflammatory protein (MIP)‐1α production and collagen‐induced arthritis by adenosine receptor agonists
C Szabó, GS Scott, L Virág, G Egnaczyk, AL Salzman, TP Shanley, ...
British journal of pharmacology 125 (2), 379-387, 1998
1911998
Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly (ADP-ribose) polymerase activation
F Soriano, L Virág, C Szabó
Journal of molecular medicine 79 (8), 437-448, 2001
1862001
Resistance to acute septic peritonitis in poly (ADP-ribose) polymerase-1-deficient mice
FG Soriano, L Liaudet, E Szabo, L Virág, JG Mabley, P Pacher, C Szabo
Shock 17 (4), 286-292, 2002
1692002
Poly (ADP-ribose) signaling in cell death
L Virág, A Robaszkiewicz, JMR Vargas, F Javier Oliver
Molecular Aspects of Medicine, 2013
1662013
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20